Andelyn Biosciences Collaborates with Tern Therapeutics to Tackle CLN2 Batten Disease with AAV Gene Therapy#USA#Columbus#Andelyn_Biosciences#AAV_Gene_Therapy#CLN2_Batten_Disease
Andelyn Biosciences Collaborates with Tern Therapeutics to Tackle CLN2 Batten Disease with AAV Gene Therapy
Andelyn Biosciences teams up with Tern Therapeutics for late-stage manufacturing of AAV gene therapy aimed at curing CLN2 Batten disease, offering hope for affected children.
third-news.com
September 3, 2025 at 12:27 PM
Andelyn Biosciences Collaborates with Tern Therapeutics to Tackle CLN2 Batten Disease with AAV Gene Therapy#USA#Columbus#Andelyn_Biosciences#AAV_Gene_Therapy#CLN2_Batten_Disease